Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.20
+0.25 (2.79%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Bioventus Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 34.54 | 54.55 | -94.1 | -391.25 | -426.78 | 19.17 |
Depreciation & Amortization | 46.35 | 47.01 | 49.56 | 57.37 | 55.4 | 34.88 |
Stock-Based Compensation | 13.52 | 12.67 | 13.27 | 2.72 | 17.59 | -4.51 |
Other Adjustments | 1.56 | 1.56 | 34.8 | 81.8 | 89.99 | -3.68 |
Change in Receivables | -2.6 | -0.92 | -10.67 | 10.06 | -17.67 | -20.05 |
Changes in Inventories | 7.8 | 8.57 | -16.44 | -5.99 | -18.62 | 3.18 |
Changes in Accounts Payable | 3.92 | -19.81 | 17.85 | -5.28 | -3.1 | 18.21 |
Changes in Other Operating Activities | 15.42 | -1.68 | -2.53 | -1.97 | 9.66 | -16.49 |
Operating Cash Flow | 102.94 | 74.67 | 38.8 | 15.34 | -13.54 | 22.99 |
Operating Cash Flow Growth | 304.17% | 92.48% | 152.84% | - | - | -67.98% |
Capital Expenditures | -2.31 | -2.56 | -1.01 | -7.36 | -1.48 | -13.52 |
Purchases of Intangible Assets | - | - | -0.71 | - | -10.04 | -7.37 |
Payments for Business Acquisitions | - | - | - | - | - | -262.87 |
Proceeds from Business Divestments | -0.69 | -0.69 | 24.68 | 34.68 | - | - |
Other Investing Activities | - | - | - | - | -0.08 | - |
Investing Cash Flow | -3 | -3.25 | 22.96 | 15.81 | -116.44 | -283.76 |
Short-Term Debt Issued | 30 | 45 | - | 64 | 25 | 20 |
Short-Term Debt Repaid | -40 | -45 | -15 | -49 | -25 | -20 |
Net Short-Term Debt Issued (Repaid) | -10 | 0 | -15 | 15 | 0 | 0 |
Long-Term Debt Issued | 31.91 | 31.91 | - | - | 79.66 | 257.45 |
Long-Term Debt Repaid | -36.35 | -74.82 | -44.58 | -38.26 | -20.04 | -91.25 |
Net Long-Term Debt Issued (Repaid) | -4.45 | -42.91 | -44.58 | -38.26 | 59.62 | 166.2 |
Issuance of Common Stock | 2.04 | 2.07 | 2.44 | 0.78 | 5.82 | 109.41 |
Repurchase of Common Stock | -1.05 | -0.01 | - | - | -3.35 | - |
Net Common Stock Issued (Repurchased) | 0.99 | 2.07 | 2.44 | 0.78 | 2.47 | 109.41 |
Other Financing Activities | -12.31 | -21.3 | 2.56 | -4.17 | -0.02 | -2.24 |
Financing Cash Flow | -86.23 | -62.14 | -54.58 | -26.65 | 62.08 | 273.37 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.67 | 0.37 | -2.56 | 0.63 | 0.52 | -0.23 |
Net Cash Flow | 13.04 | 9.66 | 4.62 | 5.13 | -67.38 | 12.37 |
Free Cash Flow | 100.63 | 72.11 | 37.79 | 7.98 | -15.02 | 9.47 |
Free Cash Flow Growth | 39.55% | 90.83% | 373.43% | - | - | -82.85% |
FCF Margin | 17.46% | 12.69% | 6.59% | 1.56% | -2.93% | 2.20% |
Free Cash Flow Per Share | 0.01 | 1.05 | 0.59 | 0.13 | -0.24 | 0.21 |
Levered Free Cash Flow | 85.23 | 11.35 | -48.27 | -142.73 | -57.22 | 211.84 |
Unlevered Free Cash Flow | 130.25 | 88.79 | 33.78 | -45.02 | -86.11 | 40.82 |